Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art.
Alfredo Paez-CarpioFernando M GómezGemma Isus OlivéPilar ParedesTarik BaetensEnrique CarreroMarcelo SánchezIvan VollmerPublished in: Insights into imaging (2021)
Image-guided percutaneous lung ablation has proven to be a valid treatment alternative in patients with early-stage non-small cell lung carcinoma or oligometastatic lung disease. Available ablative modalities include radiofrequency ablation, microwave ablation, and cryoablation. Currently, there are no sufficiently representative studies to determine significant differences between the results of these techniques. However, a common feature among them is their excellent tolerance with very few complications. For optimal treatment, radiologists must carefully select the patients to be treated, perform a refined ablative technique, and have a detailed knowledge of the radiological features following lung ablation. Although no randomized studies comparing image-guided percutaneous lung ablation with surgery or stereotactic radiation therapy are available, the current literature demonstrates equivalent survival rates. This review will discuss image-guided percutaneous lung ablation features, including available modalities, approved indications, possible complications, published results, and future applications.
Keyphrases
- radiofrequency ablation
- minimally invasive
- early stage
- radiation therapy
- healthcare
- end stage renal disease
- randomized controlled trial
- ultrasound guided
- systematic review
- risk factors
- deep learning
- machine learning
- combination therapy
- artificial intelligence
- open label
- stem cells
- double blind
- squamous cell carcinoma
- small cell lung cancer
- atrial fibrillation
- peritoneal dialysis
- prognostic factors
- sentinel lymph node
- free survival
- locally advanced